Large-scale testing (Phase 3)Not Yet RecruitingNCT07625384
What this trial is testing
Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease
Who this might be right for
Still Disease
R-Pharm International, LLC 52